Back
Kiniksa Pharmaceuticals Vs. Impinj Industry Stock Comparison
Buy
93
KNSA
Kiniksa Pharmaceuticals
Last Price:
20.27
Seasonality Move:
11.27%
Sell
49
PI
Impinj
Last Price:
163.85
Seasonality Move:
19%
Buy
93
Kiniksa Pharmaceuticals (KNSA)
is a Buy
Is Kiniksa Pharmaceuticals a Buy, Sell or Hold?
- The current Kiniksa Pharmaceuticals [KNSA] share price is $20.33. The Score for KNSA is 93, which is 86% above its historic median score of 50, and infers lower risk than normal.
- KNSA is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
49
Impinj (PI)
is a Sell
Is Impinj a Buy, Sell or Hold?
- The current Impinj [PI] share price is $165.93. The Score for PI is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- PI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KNSA Stock Price Chart
What is Kiniksa Pharmaceuticals's stock price today?
-
The Kiniksa Pharmaceuticals share price today is $20.33
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KNSA is experiencing buying pressure, which is a positive indicator for future bullish movement.
PI Stock Price Chart
KNSA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.33 | Buy |
| Relative Strength Index (14 RSI): | 70.59 | Buy |
| Chaikin Money Flow: | 168240 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.1 - 19.08) | Buy |
| Bollinger Bands (100): | (17.85 - 20.13) | Buy |
PI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 11.6 | Buy |
| Relative Strength Index (14 RSI): | 73.7 | Buy |
| Chaikin Money Flow: | 164770 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (116.66 - 153) | Buy |
| Bollinger Bands (100): | (90.29 - 131.47) | Buy |
KNSA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.29 | Buy |
| 20-day SMA: | 18.13 | Buy |
| 50-day SMA: | 19.16 | Buy |
| 200-day SMA: | 17.88 | Buy |
| 8-day EMA: | 19.4 | Buy |
| 20-day EMA: | 18.76 | Buy |
| 50-day EMA: | 18.78 | Buy |
| 200-day EMA: | 17.67 | Buy |
PI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 159.04 | Buy |
| 20-day SMA: | 137.94 | Buy |
| 50-day SMA: | 126.85 | Buy |
| 200-day SMA: | 88 | Buy |
| 8-day EMA: | 156.87 | Buy |
| 20-day EMA: | 144.02 | Buy |
| 50-day EMA: | 129.09 | Buy |
| 200-day EMA: | 103.01 | Buy |
Kiniksa Pharmaceuticals Earnings Growth & KNSA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.51 per share, and an increase next year of $0.49 per share.
Impinj Earnings Growth & PI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.50 per share, an increase next quarter of $0.47 per share, an increase this year of $1.10 per share, and an increase next year of $0.65 per share.
Kiniksa Pharmaceuticals Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Impinj Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||